3M (MMM)
(Delayed Data from NYSE)
$130.55 USD
+1.95 (1.52%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $130.41 -0.14 (-0.11%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$130.55 USD
+1.95 (1.52%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $130.41 -0.14 (-0.11%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
Zacks News
Conglomerate 3M’s focus on business transformation — with moves like the localization of decision making and integration of supply chains — enhances its competitive advantage. Also, its recognized product brands and investments in innovation are compelling. Inorganic actions (buyouts and divestments) are added advantages. Acelity, bought in October 2019, is predicted to aid 3M’s medical solutions business. Being one of the largest manufacturers of respiratory masks, the coronavirus outbreak has added to the company’s growth potential.
3M (MMM) Lags Q1 Earnings and Sales Estimates, Lowers View
by Zacks Equity Research
3M's (MMM) first-quarter 2019 results suffer from weak sales results, high costs of sales and poor operating performance. It lowers 2019 earnings projection and announces business segment realignment.
Durable Goods Orders Jump in March
by Zacks Equity Research
Durable Goods Orders Jump in March
Jobless Claims, Durable Goods Up, 3M (MMM) Down
by Mark Vickery
Jobless Claims rose to normal solid levels, while Durable Goods demonstrated strong business investment. But what about 3M?
Can Organic Sales and High Costs Hurt 3M (MMM) Q1 Earnings?
by Zacks Equity Research
3M's (MMM) first-quarter 2019 results might be impacted by lower organic sales, inflation in raw material costs, forex woes and buyout impacts. Product portfolio and key priorities might be boons.
3M (MMM) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
3M (MMM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Trends Emerging from the Q1 Earnings Season
by Sheraz Mian
The growth challenge expected this season is very real, but its not the gloom and doom that many had feared.
CSL vs. MMM: Which Stock Is the Better Value Option?
by Zacks Equity Research
CSL vs. MMM: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights: Amazon, 3M, Novartis, Schlumberger and ICICI
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, 3M, Novartis, Schlumberger and ICICI
Top Analyst Reports for Amazon, 3M & Novartis
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Amazon (AMZN), 3M (MMM) and Novartis (NVS).
This is Why 3M (MMM) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does 3M (MMM) have what it takes? Let's find out.
Should You Invest in the Fidelity MSCI Industrials Index ETF (FIDU)?
by Zacks Equity Research
Sector ETF report for FIDU
3M Stands on Solid Footing Across Markets Amid High Costs
by Zacks Equity Research
Strong product portfolio, investment in innovations and acquired assets are likely to drive 3M's (MMM) revenues despite headwinds.
CSL vs. MMM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CSL vs. MMM: Which Stock Is the Better Value Option?
Should You Invest in the Fidelity MSCI Industrials Index ETF (FIDU)?
by Zacks Equity Research
Sector ETF report for FIDU
The Zacks Analyst Blog Highlights: Nike, 3M, Vertex, PepsiCo and Verisk
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nike, 3M, Vertex, PepsiCo and Verisk
Top Stock Reports for Nike, 3M & Vertex
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Nike (NKE), 3M (MMM) and Vertex (VRTX).
Are We Heading into an Earnings Recession?
by Sheraz Mian
While growth is no doubt decelerating, it is still positive and in-line with where are in economic cycle.
Industrial ETFs Stay Strong Despite Mixed Earnings
by Sanghamitra Saha
Signs of improvement in trade relations between the United States and China and the Fed???s dovish stance have helped industrial ETFs despite mixed earnings.
Stock Market News For Feb 13, 2019
by Zacks Equity Research
U.S. markets closed at their highest levels for 2019 on Tuesday.
Should You Invest in the Fidelity MSCI Industrials Index ETF (FIDU)?
by Sweta Killa
Sector ETF report for FIDU
Dow 30 Stock Roundup: MCD, BA, 3M, MSFT, PFE, V Earnings Impress
by Swarup Gupta
The index enjoyed a strong week overall, bolstered by encouraging earnings.
Apple Earnings Preview & Latest Results from Verizon, 3M, and Pfizer
by Ryan McQueeney
Ryan McQueeney recaps earnings results from Verizon, 3M, Pfizer, and Harley-Davidson. Later, he previews the upcoming report of sputtering tech behemoth Apple.
Apple To Report Fiscal Q1 Earnings
by Zacks Equity Research
Apple To Report Fiscal Q1 Earnings
The Apple (AAPL) of Investors' Eye
by Mark Vickery
With Apple (AAPL) reporting fiscal Q1 earnings results after the closing bell this afternoon, this is where the majority of attention will be.
3M (MMM) Beats Q4 Earnings Estimates, Revises '19 View Down
by Zacks Equity Research
3M's (MMM) fourth-quarter 2018 results gain from decrease in costs of sales and operating expenses as well as lower tax expenses. It lowers earnings projection for 2019.